Skip to main content
Broncus Holding Corporation logo

Broncus Holding Corporation — Investor Relations & Filings

Ticker · 2216 ISIN · KYG1609T1022 HKEX Manufacturing
Open in API
Filings indexed 198 across all filing types
Latest filing 2021-09-06 Regulatory Filings
Country HK Hong Kong
Listing HKEX 2216

About Broncus Holding Corporation

http://www.broncus.com

Broncus Holding Corporation is a medical device company focused on the research, development, manufacturing, and commercialization of innovative solutions for lung diseases. The company is recognized as a pioneer in the field of interventional pulmonology. Broncus provides comprehensive solutions across the spectrum of lung care, including advanced diagnostic solutions, lung cancer treatment solutions, and specialized solutions for chronic obstructive pulmonary disease (COPD). Its product portfolio consists of medical devices and consumables designed to improve patient outcomes in global markets, including Mainland China and the European Union.

Recent filings

Filing Released Lang Actions
PHIP (1st submission)
Regulatory Filings Classification · 95% confidence The document is titled 'Post Hearing Information Pack' and is issued in draft form by Broncus Holding Corporation. It contains disclaimers about the document being incomplete and subject to change, warnings about investment decisions, and references to the Stock Exchange of Hong Kong Limited and the Securities and Futures Commission. The content includes expected timetables, risk factors, waiver information, and other preparatory details related to a public offering or listing application. There is no indication that this is a final report such as an Annual Report, Interim Report, or Earnings Release. Instead, it is a regulatory disclosure document related to a listing or offering process, providing information post-hearing with the exchange and commission. The document is not a proxy solicitation, voting results, or management change announcement. It is not a certification or audit report. Given the nature of the document as a regulatory disclosure related to a listing application and the absence of substantive financial statements or final report data, the best fitting category is Regulatory Filings (RNS). The document is lengthy (15,000 characters) and contains detailed information but is not a formal financial report or presentation. Therefore, the classification is RNS with high confidence.
2021-09-06 English
Application Proof (1st submission)
Audit Report / Information Classification · 95% confidence The document is an 'Application Proof' from the HKEX (Hong Kong Stock Exchange) website for Broncus Holding Corporation. It lists various sections and appendices typical of an IPO prospectus (e.g., 'Accountants' Report', 'Industry Overview', 'Structure of the [REDACTED]'). Since the document acts as a portal or index for the various components of a listing application/prospectus, and does not fit into the other specific categories, it is classified as a Regulatory Filing (RNS). FY 2020
2021-05-10 English
Application Proof (1st submission)
Capital/Financing Update Classification · 95% confidence The document is titled 'Application Proof' and contains multiple disclaimers stating it is a draft, incomplete, and subject to change. It references the Stock Exchange of Hong Kong Limited and the Securities and Futures Commission, indicating it is related to a securities listing process. The text repeatedly emphasizes that this document is not a prospectus or an offer to sell securities and that it is for informational purposes only in connection with a potential public offering. There are references to an expected timetable, risk factors, and other sections typical of a listing or offering document. The document is not a final report, financial statement, or regulatory filing but rather a draft application proof related to an initial public offering or listing application. This aligns with a Capital/Financing Update (CAP) category, which covers updates on company fundraising and capital structure changes. The document length is substantial (15,000 characters), and it is not merely an announcement of a report but a detailed draft document related to capital raising. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2021-05-10 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.